Researchers have disclosed compounds reported to be useful for the treatment of cancer and more.

The company will develop a pipeline of small molecule inhibitors that target a unique lipid-binding pocket on proteins.

Outlook Therapeutics Inc. is forging onward with plans to resubmit the BLA for ONS-5010, an ophthalmic version of Avastin (bevacizumab, Roche AG), after a missed ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Cicmil is particularly interested in proteins with hydrophobic pockets—potential binding sites for new drugs—that undergo the process of autopalmitoylation, which determines where the protein goes and ...

The per­son­nel situa­ti­on has impro­ved. Ameen Al-Dak­hil appears to have final­ly reco­ver­ed from his ill­ness. Howe­ver, ...

This personal advice column was one of November's most tead articles. Q I’m a 63-year-old retired public-sector worker. As I worked in the UK in the 1980s and paid National Insurance ...

New research shows how unhealthy food and lifestyle habits have damaged Indian guts, causing a raft of serious physical and ...

Lawmakers in s tead decided to send out a survey in order to get a better idea of what backup power sources already exist. In Wednesday’s hearing, Dionne-Vahalik noted more than half of the ...